Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019, and the resulting pandemic has already caused the death of over 6 million people. There are currently few antivirals approved for treatment of the 2019 coronavirus disease (COVID-19), and more options would be beneficial,...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado-Benvindo, Clarisse, Leijs, Anouk A., Thaler, Melissa, Tas, Ali, Arbiser, Jack L., Snijder, Eric J., van Hemert, Martijn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269499/
https://www.ncbi.nlm.nih.gov/pubmed/37212560
http://dx.doi.org/10.1128/spectrum.03273-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269499/
https://www.ncbi.nlm.nih.gov/pubmed/37212560
http://dx.doi.org/10.1128/spectrum.03273-22

Ejemplares similares